# Verapamil SR in Adults With Type 1 Diabetes

> **NCT04545151** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Medical University of Graz** · enrollment: 138 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Verapamil SR 120 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04545151
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-08
- **Primary completion:** 2025-05
- **Final completion:** 2026-05
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2024-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04545151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04545151, "Verapamil SR in Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04545151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*